Because TG and CGRP are critical in migraine pathophysiology and considering our finding that TRPC4 is highly expressed in TG tissues and its inhibition reduced CGRP in a model of psoriasis (Lee et al., 2020), we asked if TRPC4 inhibition may offer a therapeutic option for the treatment of migraine. The gene discussed is TRPC4; the disease is migraine disorder.